VOCABRIA (cabotegravir) + REKAMBYS (rilpivirine) data from OPERA Real World study

VOCABRIA ▼ (cabotegravir) + REKAMBYS ▼ data from OPERA Real World study

PM-GB-HVX-WCNT-220003 | August 2026

Adverse event reporting

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK via the GSK Reporting Tool or on 0800 221441.